Screen2Prevent (S2P)
NCT07728123
This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- HIV Infections
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 14 to 24 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Westat
- Last updated on ClinicalTrials.gov
- August 17, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- University of South Florida · Tampa, FL
Georgia · 1
- Emory Atlanta Adolescent Consortium · Atlanta, GA
Maryland · 1
- Johns Hopkins University · Baltimore, MD
Tennessee · 1
- St. Jude Children's Research Hospital · Memphis, TN
Texas · 1
- Baylor College of Medicine · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.